Get startedLog in
    Picture of Acorda Therapeutics logo

    ACORQ — Acorda Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Acorda Therapeutics Q2 Non-GAAP Loss Per Share $1.87

    Picture of Acorda Therapeutics logoAcorda Therapeutics
    05/08/2021 21:25
    Aug 5 (Reuters) - Acorda Therapeutics Inc  ACOR.O :
    * ACORDA THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
    * Q2 NON-GAAP LOSS PER SHARE $1.87
    * Q2 GAAP LOSS PER SHARE $2.29
    * SAYS FOR FULL-YEAR 2021, CO CONTINUES TO EXPECT AMPYRA NET
REVENUE TO BE $75 MILLION - $85 MILLION

Source text for Eikon:  ID:nBwbKz5RYa 
Further company coverage:  ACOR.O

    Recent news on Acorda Therapeutics

    See all news